256 related articles for article (PubMed ID: 36298629)
1. Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network.
Papanikolaou C; Rapti V; Stellas D; Stefanou DT; Syrigos K; Pavlakis GN; Souliotis VL
Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298629
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 and the DNA damage response.
Grand RJ
J Gen Virol; 2023 Nov; 104(11):. PubMed ID: 37948194
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 triggers DNA damage response in Vero E6 cells.
Victor J; Deutsch J; Whitaker A; Lamkin EN; March A; Zhou P; Botten JW; Chatterjee N
Biochem Biophys Res Commun; 2021 Nov; 579():141-145. PubMed ID: 34600299
[TBL] [Abstract][Full Text] [Related]
4. [Interaction between SARS-CoV-2 and Host Innate Immunity].
Duan XQ; Xie H; Chen LM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):1-6. PubMed ID: 35048592
[TBL] [Abstract][Full Text] [Related]
5. COVID-19: imbalanced cell-mediated immune response drives to immunopathology.
Wang J; Li Q; Qiu Y; Lu H
Emerg Microbes Infect; 2022 Dec; 11(1):2393-2404. PubMed ID: 36069182
[TBL] [Abstract][Full Text] [Related]
6. DNA damage response at telomeres boosts the transcription of SARS-CoV-2 receptor ACE2 during aging.
Sepe S; Rossiello F; Cancila V; Iannelli F; Matti V; Cicio G; Cabrini M; Marinelli E; Alabi BR; di Lillo A; Di Napoli A; Shay JW; Tripodo C; d'Adda di Fagagna F
EMBO Rep; 2022 Feb; 23(2):e53658. PubMed ID: 34854526
[TBL] [Abstract][Full Text] [Related]
7. The consequences of viral infection on host DNA damage response: a focus on SARS-CoVs.
Mekawy AS; Alaswad Z; Ibrahim AA; Mohamed AA; AlOkda A; Elserafy M
J Genet Eng Biotechnol; 2022 Jul; 20(1):104. PubMed ID: 35829826
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary medical insights into the SARS-CoV-2 pandemic.
Crespi B
Evol Med Public Health; 2020; 2020(1):314-322. PubMed ID: 33335737
[TBL] [Abstract][Full Text] [Related]
10. Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines.
Yang Y; Iwasaki A
Curr HIV/AIDS Rep; 2022 Feb; 19(1):5-16. PubMed ID: 34843064
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial derived cells and cardiomyocytes.
Li Y; Renner DM; Comar CE; Whelan JN; Reyes HM; Cardenas-Diaz FL; Truitt R; Tan LH; Dong B; Alysandratos KD; Huang J; Palmer JN; Adappa ND; Kohanski MA; Kotton DN; Silverman RH; Yang W; Morrisey E; Cohen NA; Weiss SR
bioRxiv; 2020 Nov; ():. PubMed ID: 32995797
[TBL] [Abstract][Full Text] [Related]
12. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion.
Low ZY; Zabidi NZ; Yip AJW; Puniyamurti A; Chow VTK; Lal SK
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146796
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
15. Immunological and Hematological Response in COVID-19.
Słomka A; Martucci G; Raffa GM; Malvindi PG; Żekanowska E; Lorusso R; Suwalski P; Kowalewski M
Adv Exp Med Biol; 2021; 1352():73-86. PubMed ID: 35132595
[TBL] [Abstract][Full Text] [Related]
16. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Antibody Response among Women Infected during Pregnancy.
Buckley A; Mills A; Paul K; Raymond S; Mendu DR; DeBolt C; Rosenberg M; Wajnberg A; Szeto L; Cochrane E; Vieira L; Berkin J; Ferrera L; Stone J; Bianco A
Am J Perinatol; 2022 May; 39(7):707-713. PubMed ID: 34768307
[TBL] [Abstract][Full Text] [Related]
18. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
19. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2.
Lawal IO; Kgatle MM; Mokoala K; Farate A; Sathekge MM
BMC Cardiovasc Disord; 2022 Mar; 22(1):93. PubMed ID: 35264107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]